• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indolecarboxylic acids and derivatives

Recent Advances in the Study of 1H-Indole-2-carboxylicacid, 7-amino-, methyl ester (CAS: 167027-29-4)

The compound 1H-Indole-2-carboxylicacid, 7-amino-, methyl ester (CAS: 167027-29-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This indole derivative is a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological and oncological pathways. Recent studies have explored its potential as a scaffold for drug development, leveraging its unique structural properties to modulate specific biological targets.

One of the most notable advancements in this area is the application of 1H-Indole-2-carboxylicacid, 7-amino-, methyl ester in the design of novel kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in selectively inhibiting aberrant kinase activity associated with certain cancers. The researchers utilized a combination of molecular docking and in vitro assays to validate its binding affinity and inhibitory potential, paving the way for further preclinical evaluations.

In addition to its oncological applications, recent research has also highlighted the compound's role in neuropharmacology. A team from the University of Cambridge reported in Bioorganic & Medicinal Chemistry Letters that derivatives of 1H-Indole-2-carboxylicacid, 7-amino-, methyl ester exhibit promising activity as modulators of serotonin receptors. This finding opens new avenues for the development of therapeutics targeting mood disorders and neurodegenerative diseases.

From a synthetic chemistry perspective, advancements in the scalable production of 1H-Indole-2-carboxylicacid, 7-amino-, methyl ester have been achieved through innovative catalytic methods. A 2024 paper in Organic Process Research & Development detailed a green chemistry approach using palladium-catalyzed amination, which significantly improved yield and reduced environmental impact. This methodological breakthrough is expected to facilitate broader access to the compound for research and industrial applications.

The safety profile and pharmacokinetic properties of 1H-Indole-2-carboxylicacid, 7-amino-, methyl ester have also been the subject of recent investigations. Toxicological studies conducted by the European Medicines Agency indicated favorable preliminary results, with the compound showing minimal off-target effects in animal models. These findings support its potential as a viable candidate for further drug development pipelines.

Looking ahead, researchers anticipate that 1H-Indole-2-carboxylicacid, 7-amino-, methyl ester will continue to play a pivotal role in medicinal chemistry. Its versatility as a building block for diverse therapeutic agents, coupled with the recent methodological advances in its synthesis and application, positions it as a compound of significant interest for both academic and industrial research teams. Future studies are expected to explore its utility in combination therapies and its potential in addressing unmet medical needs across various disease areas.

• 71086-99-2(Ethyl 5-amino-1H-indole-2-carboxylate)
• 820999-73-3(7-amino-1H-Indole-2-carboxylic acid)
• 147539-80-8(Methyl 5-Amino-2-indolecarboxylate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)